Performance of FDG-PET, SRS and CT for diagnosis of well differentiated endocrine carcinomas with high Ki67 (≥10%).

被引:0
|
作者
Abgral, R. [1 ]
Leboulleux, S. [1 ]
Deandreis, D. [1 ]
Auperin, A. [1 ]
Dromain, C. [1 ]
Duvillard, P. [1 ]
Lumbroso, J. [1 ]
Schlumberger, M. [1 ]
Ducreux, M. [1 ]
Baudin, E. [1 ]
机构
[1] Inst Gustave Roussy, Villejuif, France
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S273 / S273
页数:1
相关论文
共 50 条
  • [1] Diagnosis of well differentiated endocrine carcinomas (WDEC) with elevated Ki67 expression (≥10%): FDG-PET or SRS?
    Abgral, Ronan
    Abgral, Ronan
    Duvillard, Pierre
    Auperin, Anne
    Deandreis, Desiree
    Dromain, Clarisse
    Lumbroso, Jean
    Schlumberger, Martin
    Baudin, Eric
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [2] Diagnosis of Well-Differentiated Endocrine Carcinomas with High Ki-67 (≥10%): FDG-PET or SRS?
    Abgral, R.
    Leboulleux, S.
    Deandreis, D.
    Auperin, A.
    Dromain, C.
    Lumbroso, J.
    Schlumberger, M.
    Ducreux, M.
    Baudin, E.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 93 - 93
  • [3] Impact of FDG PET/CT in directing management of well differentiated neuroendocrine tumours with Ki67 <5%
    Agrawal, A.
    Choudhary, S.
    Puranik, A.
    Rangarajan, V.
    Shrikhande, S.
    Bal, M.
    Choudhary, V.
    Bhandare, M.
    Ramaswamy, A.
    Purandare, N.
    Shah, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S544 - S544
  • [4] Does FDG-PET uptake correlate with grade and Ki67 in follicular lymphoma?
    Colleter, L.
    Ohnona, J.
    Lussato, D.
    Thieblemont, C.
    Brice, P.
    De Bazelaire, C.
    Briere, J.
    Merlet, P.
    De Kerviler, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S476 - S476
  • [5] Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging
    Abgral, Ronan
    Leboulleux, Sophie
    Deandreis, Desiree
    Auperin, Anne
    Lumbroso, Jean
    Dromain, Clarisse
    Duvillard, Pierre
    Elias, Dominique
    de Baere, Thierry
    Guigay, Joel
    Ducreux, Michel
    Schlumberger, Martin
    Baudin, Eric
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03): : 665 - 671
  • [6] Impact of FDG PET/CT Scan in Changing Management of Well-Differentiated Neuroendocrine Tumors With Ki67 Index Less Than or Equal to 5%
    Choudhury, Sayak
    Agrawal, Archi
    Rangarajan, Venkatesh
    Puranik, Ameya
    Bal, Munita
    Chaudhari, Vikram
    Bhandare, Manish
    Purandare, Nilendu
    Shah, Sneha
    Ramaswamy, Anant
    Ostwal, Vikas
    Shrikhande, Shailesh, V
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : E676 - E681
  • [7] Correlation of Ki67 expression with FDG-PET positivity in triple negative breast cancer.
    Tchou, J.
    John, T.
    Basu, S.
    Rosen, M.
    Schnall, M.
    Alavi, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S49 - S49
  • [8] Correlation between metabolic tumor burden at [18F]FDG-PET/CT and Ki67 index in neuroendocrine tumors
    Massri, K.
    Duce, V.
    Margotti, S.
    Volterrani, D.
    Boni, R.
    Grosso, M.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S377 - S377
  • [9] Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer
    Kitajima, Kazuhiro
    Murakami, Koji
    Yamasaki, Erena
    Hagiwara, Shingo
    Fukasawa, Ichio
    Inaba, Noriyuki
    Kaji, Yasushi
    Sugimura, Kazuro
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (02) : 103 - 109
  • [10] Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer
    Kazuhiro Kitajima
    Koji Murakami
    Erena Yamasaki
    Shingo Hagiwara
    Ichio Fukasawa
    Noriyuki Inaba
    Yasushi Kaji
    Kazuro Sugimura
    Annals of Nuclear Medicine, 2008, 22 : 103 - 109